NCT02368457View on ClinicalTrials.gov

Management of Mandibular ORN: PENTO as Medical Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

February 29, 2016

Study Completion Date

January 1, 2018

Conditions
Osteoradionecrosis
Interventions
DRUG

Pentoxifylline and Tocopherol

pentoxifylline with tocopherol Pentoxifylline 800 mg/day, oral (1cp 400 mg twice a day) + Vitamin E (alfa-tocopherol) 1000 UI/day, oral (1cp 400UI twice a day + 1cp200UI once a day) during 24 months (maximum).

Trial Locations (1)

08035

Vall d'Hebrón Hospital, Barcelona

All Listed Sponsors
lead

Hospital Vall d'Hebron

OTHER

NCT02368457 - Management of Mandibular ORN: PENTO as Medical Treatment | Biotech Hunter | Biotech Hunter